(Q30493655)

English

Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds (English)

1 reference

Europe PubMed Central

13 September 2017

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

Raffaella Giavazzi

9

1 reference

Europe PubMed Central

13 September 2017

Simona Tomaselli

object named as

Simona Tomaselli

8

0 references

Matteo Stravalaci

object named as

Matteo Stravalaci

7

0 references

Giulia Taraboletti

object named as

Giulia Taraboletti

16

0 references

object named as

Marco Rusnati

10

0 references

Giorgio Colombo

object named as

Giorgio Colombo

1

0 references

object named as

Marco Gobbi

15

0 references

object named as

Marco Presta

11

0 references

Domenico Ribatti

14

object named as

Domenico Ribatti

1 reference

Europe PubMed Central

13 September 2017

Barbara Margosio

2

object named as

Barbara Margosio

1 reference

Europe PubMed Central

13 September 2017

Douglas S Annis

6

object named as

Douglas S Annis

1 reference

Europe PubMed Central

13 September 2017

13

object named as

Deane F Mosher

1 reference

Europe PubMed Central

13 September 2017

3

object named as

Laura Ragona

1 reference

Europe PubMed Central

13 September 2017

Silvia Bonifacio

5

object named as

Silvia Bonifacio

1 reference

Europe PubMed Central

13 September 2017

12

object named as

Lucia Zetta

1 reference

Europe PubMed Central

13 September 2017

author name string

Marco Neves

4

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

7 January 2010

1 reference

Europe PubMed Central

13 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

13 September 2017

285

1 reference

Europe PubMed Central

13 September 2017

12

1 reference

Europe PubMed Central

13 September 2017

8733-8742

1 reference

Europe PubMed Central

13 September 2017

Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

The FGF family: biology, pathophysiology and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Differences between high- and low-affinity complexes of enzymes and nonenzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

The design, structures and therapeutic potential of protein epitope mimetics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Modes of resistance to anti-angiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Structures of thrombospondins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Thrombospondins in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Developing antiangiogenic peptide drugs for angiogenesis-related diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Thrombospondin-based antiangiogenic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Targeting protein-protein interactions: lessons from p53/MDM2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Angiogenesis: an organizing principle for drug discovery?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Modelling of the complex between a 15-residue peptide from mSos2 and the N-terminal SH3 domain of Grb2 by molecular-dynamics simulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Hot-spot mimicry of a cytokine receptor by a small molecule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Between a rock and a hard place?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Angiogenesis in life, disease and medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Structure of the calcium-rich signature domain of human thrombospondin-2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Endogenous inhibitors of angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Rational design of shepherdin, a novel anticancer agent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Thrombospondin modules and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Modulation of protein-protein interactions with small organic molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Thrombospondins 1 and 2 function as inhibitors of angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Matricellular proteins: extracellular modulators of cell function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Structural aspects of antibody-antigen interaction revealed through small random peptide libraries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

A hot spot of binding energy in a hormone-receptor interface

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2838296

20 June 2018

A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

Semianalytical treatment of solvation for molecular mechanics and dynamics

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

The gelatin sponge-chorioallantoic membrane assay.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

National Cancer Institute Drug Information System 3D database.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

Single-chain antibody fragments derived from a human synthetic phage-display library bind thrombospondin and inhibit sickle cell adhesion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M109.085605

21 January 2018

Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploring "one-shot" kinetics and small molecule analysis using the ProteOn XPR36 array biosensor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombospondin 1 as an enzyme inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20056600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1074/JBC.M109.085605

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30493655&oldid=1859027402"